Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

430
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
430
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

More Than an Effective Latch.

Nursing for women's health·2026
Same author

A Participatory Investigation of Breastfeeding Behavior in the Pakistani Community in the United Kingdom.

Journal of nutrition education and behavior·2026
Same author

Caregivers' views on paediatric burn injury prevention materials in the United Kingdom.

Burns : journal of the International Society for Burn Injuries·2026
Same author

Endometrial Endometrioid Carcinomas With Signet Ring Cells: Report of a Case Series With Detailed Clinical, Pathologic, and Molecular Analysis.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists·2026
Same author

The association between cerebrospinal fluid interleukin-6, soluble interleukin-6 receptor, and interleukin-6 trans-signalling binary complex with postoperative delirium: an observational cohort study.

BJA open·2026
Same author

Status of Lactation Support for Urologists: Results and Recommendations From a Society of Women in Urology Parenting in Urology Task Force American Urologic Association Survey.

Urology·2026

Related Experiment Video

Updated: May 2, 2026

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)
09:38

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)

Published on: September 5, 2025

1.1K

News from the MINERVA trial.

Jennifer Taylor

    European Heart Journal
    |March 20, 2014
    PubMed
    Summary

    The MINERVA randomized study evaluated treatments for atrial fibrillation. Results demonstrated a specific therapeutic approach

    Area of Science:

    • Cardiology
    • Clinical Trials

    Background:

    • Atrial fibrillation management remains a clinical challenge.
    • Optimizing treatment strategies for atrial fibrillation is crucial.

    Discussion:

    • Giuseppe Boriani presented the findings of the MINERVA study.
    • The presentation highlighted key outcomes and implications for atrial fibrillation management.

    Key Insights:

    • The study provided valuable data on the efficacy and safety of specific interventions for atrial fibrillation.
    • Results informed clinical practice guidelines for patients with this condition.

    Outlook:

    • Further research may build upon the MINERVA study's findings to explore novel therapeutic strategies.
    • Continued investigation into atrial fibrillation management remains crucial for improving patient outcomes.

    More Related Videos

    Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
    07:14

    Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

    Published on: May 23, 2025

    1.9K
    Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
    09:38

    Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

    Published on: January 31, 2025

    1.2K

    Related Experiment Videos

    Last Updated: May 2, 2026

    Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)
    09:38

    Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)

    Published on: September 5, 2025

    1.1K
    Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
    07:14

    Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

    Published on: May 23, 2025

    1.9K
    Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
    09:38

    Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity

    Published on: January 31, 2025

    1.2K